Amphetamine-Dextroamphetamine Extended Release

Amphetamine-dextroamphetamine extended release is a drug used to treat attention deficit hyperactivity disorder (ADHD). Although it is not entirely clear how amphetamine-dextroamphetamine extended release works, it is known that the medication affects chemicals in the brain to cause a calming effect in people with ADHD. There are some potential side effects of the medication, including headaches, abdominal pain, and weight loss. Amphetamine-dextroamphetamine extended release is designed to be taken once daily in the morning so that it will not cause sleeping problems.

 

What Is Amphetamine-Dextroamphetamine Extended Release?

Amphetamine-dextroamphetamine extended release (Adderall XR®) is a prescription medication that is used to treat attention deficit hyperactivity disorder (ADHD). Because this medicine is an amphetamine and is commonly abused, there are special rules for prescribing it (see Adderall: A Controlled Substance).
 
(Click What Is Amphetamine-Dextroamphetamine Extended Release Used For? for more information on uses of amphetamine-dextroamphetamine extended release, including possible off-label uses.)
 

Who Makes Amphetamine-Dextroamphetamine Extended Release?

Amphetamine-dextroamphetamine extended release is manufactured by Shire US, Inc.
 

How Does Amphetamine-Dextroamphetamine Extended Release Work?

Amphetamine-dextroamphetamine extended release is a stimulant, although it has effects that are opposite from what would be expected of a stimulant.
 While stimulants (like caffeine) can cause hyperactivity, this drug can have a calming effect. While the exact way the medication produces a calming effect is not known, it is known that amphetamine-dextroamphetamine extended release affects chemicals in the brain.
 
Amphetamine-dextroamphetamine extended release is a medication that is designed to dissolve slowly. Because the medication is released slowly, it can be taken just once a day, eliminating the need to take medication at school or work.
 
(Amphetamine-Dextroamphetamine Extended Release Continued: Page 2)
Add this article to your Favorites     Email this article     Print
Written by/reviewed by: Kristi Monson, PharmD; Arthur Schoenstadt, MD
Last reviewed by: Kristi Monson, PharmD;